Dilemma’s rond lymfadenopathie na covid-19-vaccinatie
Uložené v:
| Názov: | Dilemma’s rond lymfadenopathie na covid-19-vaccinatie |
|---|---|
| Autori: | Davidson, Linda, van Nieuwkoop, Cees, Platteel, Tamara N, Kartachova, Marina S, Kant, Agnes C, van Hunsel, Florence P A M |
| Zdroj: | Nederlands Tijdschrift voor Geneeskunde. 169 |
| Informácie o vydavateľovi: | NLM (Medline), 2025. |
| Rok vydania: | 2025 |
| Predmety: | Lymphadenopathy/etiology, Time Factors, SARS-CoV-2, COVID-19/prevention & control, Humans, Vaccination/adverse effects, Female, COVID-19 Vaccines/adverse effects |
| Popis: | Reactive lymphadenopathy after COVID-19 vaccination occurs frequently and usually recovers within 1-2 weeks. It can, however, persist for more than six months in some cases. Axillary lymphadenopathy at the site of vaccination is most common. Cervical and supraclavicular lymphadenopathy is also reported. A wait-and-see approach for 2-3 weeks seems justified when time between onset of lymphadenopathy and covid-19 vaccination is several days to weeks, there is no progression, lymphadenopathy is unilateral and localised axillary or cervical in patients without a history of malignancy and without alarm symptoms. In cases of persistent lymphadenopathy, ultrasound of the affected lymph node is recommended. In cases of unilateral axillary lymphadenopathy in women, breast examination with mammography and/or breast ultrasound is also warranted. In the absence of any abnormalities referral to secondary care can be delayed for 8-12 weeks. After this time period we advise referral to secondary care to exclude any underlying illness. |
| Druh dokumentu: | Article |
| Jazyk: | Dutch; Flemish |
| ISSN: | 1876-8784 0028-2162 |
| Prístupová URL adresa: | https://research.rug.nl/en/publications/c04c5204-0d93-4c7a-9d3f-5393581da89b https://hdl.handle.net/11370/c04c5204-0d93-4c7a-9d3f-5393581da89b |
| Prístupové číslo: | edsair.dris...01423..f903968610c36d8bbbdce66e62a4f493 |
| Databáza: | OpenAIRE |
Nájsť tento článok vo Web of Science | FullText | Text: Availability: 0 CustomLinks: – Url: https://explore.openaire.eu/search/publication?articleId=dris___01423%3A%3Af903968610c36d8bbbdce66e62a4f493 Name: EDS - OpenAIRE (s4221598) Category: fullText Text: View record at OpenAIRE – Url: https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=EBSCO&SrcAuth=EBSCO&DestApp=WOS&ServiceName=TransferToWoS&DestLinkType=GeneralSearchSummary&Func=Links&author=Davidson%20L Name: ISI Category: fullText Text: Nájsť tento článok vo Web of Science Icon: https://imagesrvr.epnet.com/ls/20docs.gif MouseOverText: Nájsť tento článok vo Web of Science |
|---|---|
| Header | DbId: edsair DbLabel: OpenAIRE An: edsair.dris...01423..f903968610c36d8bbbdce66e62a4f493 RelevancyScore: 1002 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 1002.21820068359 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Dilemma’s rond lymfadenopathie na covid-19-vaccinatie – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Davidson%2C+Linda%22">Davidson, Linda</searchLink><br /><searchLink fieldCode="AR" term="%22van+Nieuwkoop%2C+Cees%22">van Nieuwkoop, Cees</searchLink><br /><searchLink fieldCode="AR" term="%22Platteel%2C+Tamara+N%22">Platteel, Tamara N</searchLink><br /><searchLink fieldCode="AR" term="%22Kartachova%2C+Marina+S%22">Kartachova, Marina S</searchLink><br /><searchLink fieldCode="AR" term="%22Kant%2C+Agnes+C%22">Kant, Agnes C</searchLink><br /><searchLink fieldCode="AR" term="%22van+Hunsel%2C+Florence+P+A+M%22">van Hunsel, Florence P A M</searchLink> – Name: TitleSource Label: Source Group: Src Data: <i>Nederlands Tijdschrift voor Geneeskunde</i>. 169 – Name: Publisher Label: Publisher Information Group: PubInfo Data: NLM (Medline), 2025. – Name: DatePubCY Label: Publication Year Group: Date Data: 2025 – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Lymphadenopathy%2Fetiology%22">Lymphadenopathy/etiology</searchLink><br /><searchLink fieldCode="DE" term="%22Time+Factors%22">Time Factors</searchLink><br /><searchLink fieldCode="DE" term="%22SARS-CoV-2%22">SARS-CoV-2</searchLink><br /><searchLink fieldCode="DE" term="%22COVID-19%2Fprevention+%26+control%22">COVID-19/prevention & control</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Vaccination%2Fadverse+effects%22">Vaccination/adverse effects</searchLink><br /><searchLink fieldCode="DE" term="%22Female%22">Female</searchLink><br /><searchLink fieldCode="DE" term="%22COVID-19+Vaccines%2Fadverse+effects%22">COVID-19 Vaccines/adverse effects</searchLink> – Name: Abstract Label: Description Group: Ab Data: Reactive lymphadenopathy after COVID-19 vaccination occurs frequently and usually recovers within 1-2 weeks. It can, however, persist for more than six months in some cases. Axillary lymphadenopathy at the site of vaccination is most common. Cervical and supraclavicular lymphadenopathy is also reported. A wait-and-see approach for 2-3 weeks seems justified when time between onset of lymphadenopathy and covid-19 vaccination is several days to weeks, there is no progression, lymphadenopathy is unilateral and localised axillary or cervical in patients without a history of malignancy and without alarm symptoms. In cases of persistent lymphadenopathy, ultrasound of the affected lymph node is recommended. In cases of unilateral axillary lymphadenopathy in women, breast examination with mammography and/or breast ultrasound is also warranted. In the absence of any abnormalities referral to secondary care can be delayed for 8-12 weeks. After this time period we advise referral to secondary care to exclude any underlying illness. – Name: TypeDocument Label: Document Type Group: TypDoc Data: Article – Name: Language Label: Language Group: Lang Data: Dutch; Flemish – Name: ISSN Label: ISSN Group: ISSN Data: 1876-8784<br />0028-2162 – Name: URL Label: Access URL Group: URL Data: <link linkTarget="URL" linkTerm="https://research.rug.nl/en/publications/c04c5204-0d93-4c7a-9d3f-5393581da89b" linkWindow="_blank">https://research.rug.nl/en/publications/c04c5204-0d93-4c7a-9d3f-5393581da89b</link><br /><link linkTarget="URL" linkTerm="https://hdl.handle.net/11370/c04c5204-0d93-4c7a-9d3f-5393581da89b" linkWindow="_blank">https://hdl.handle.net/11370/c04c5204-0d93-4c7a-9d3f-5393581da89b</link> – Name: AN Label: Accession Number Group: ID Data: edsair.dris...01423..f903968610c36d8bbbdce66e62a4f493 |
| PLink | https://erproxy.cvtisr.sk/sfx/access?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsair&AN=edsair.dris...01423..f903968610c36d8bbbdce66e62a4f493 |
| RecordInfo | BibRecord: BibEntity: Languages: – Text: Dutch; Flemish Subjects: – SubjectFull: Lymphadenopathy/etiology Type: general – SubjectFull: Time Factors Type: general – SubjectFull: SARS-CoV-2 Type: general – SubjectFull: COVID-19/prevention & control Type: general – SubjectFull: Humans Type: general – SubjectFull: Vaccination/adverse effects Type: general – SubjectFull: Female Type: general – SubjectFull: COVID-19 Vaccines/adverse effects Type: general Titles: – TitleFull: Dilemma’s rond lymfadenopathie na covid-19-vaccinatie Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Davidson, Linda – PersonEntity: Name: NameFull: van Nieuwkoop, Cees – PersonEntity: Name: NameFull: Platteel, Tamara N – PersonEntity: Name: NameFull: Kartachova, Marina S – PersonEntity: Name: NameFull: Kant, Agnes C – PersonEntity: Name: NameFull: van Hunsel, Florence P A M IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 08 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 18768784 – Type: issn-print Value: 00282162 – Type: issn-locals Value: edsair Numbering: – Type: volume Value: 169 Titles: – TitleFull: Nederlands Tijdschrift voor Geneeskunde Type: main |
| ResultId | 1 |